Fingerprint
Dive into the research topics of 'Hormone replacement therapy after oophorectomy and breast cancer risk among BRCA1 mutation carriers'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Hormone replacement therapy after oophorectomy and breast cancer risk among BRCA1 mutation carriers
Hereditary Breast Cancer Clinical Study Group
- University of Toronto
- Pomeranian Medical University in Szczecin
- Cedars-Sinai Medical Center
- Beth Israel Deaconess Medical Center
- University of Oslo
- Creighton University
- Ohio State University
- Medical University of Vienna
- McGill University
- Vanderbilt University
- Center for Personalized Genetic Healthcare
- Beckman Research Institute of City of Hope
- Western University
- McMaster University
- Sheba Medical Center at Tel Hashomer
- North York General Hospital
- Women's College Research Institute
- Sunnybrook Health Sciences Centre
- Princess Margaret Cancer Centre
- City of Hope National Medical Center
- British Columbia Cancer Agency
- Mayo Clinic
- Fondazione IRCCS Istituto Nazionale dei Tumori
- University of Turin
- Fox Chase Cancer Center
- Cincinnati Children's Hospital Medical Center
- Northwestern University
- University of Vermont
- Royal University Hospital
- University of Manitoba
- Icahn School of Medicine at Mount Sinai
Research output: Contribution to journal › Article › peer-review
139
Scopus
citations